top of page

HOME / RİSK YÖNETİMİ / PMS-RİSK YÖNETİM PLANI

PMS-Risk Management Plan

PMS-Risk Yönetim Planı

PMS-RYP

Plan

After Market Inspection

 

General

A Risk Management Plan has been created to plan risk management activities in accordance with the relevant standards. The purpose of this plan is to ensure that the Medical Products manufactured by BÖLÜKBAŞI PHARMACEUTICALS  It aims to start the manufacturing process and to identify possible risks, to start working to rank risk criteria, to take measures and to follow up the measures and products.

In addition to the revisions made within the scope of routine improvements, this plan is revised in cases such as changes in personnel in the risk management team, changes in product production process stages, changes in equipment machine components, infrastructure changes, supplier changes.

Scope of the Risk Management System

The purpose of this plan is to determine the risks that may occur in the production process, to evaluate, reduce and identify the high risks that may cause the loss of potential customers exposed during its use by the end user. This plan is followed by evaluating the risk activity throughout the shelf life of the product, taking into account the continuity of risk throughout the shelf life of the product. 5x5 risk matrix was used for risk analysis. Probability and severity levels are based on EN 14971:2013 Standard requirements.

PMS-Plan.jpg
logo.png

The content on this site is for informational purposes only.

Consult a physician or pharmacist for more information.

+90 242 334 31 34

  • LinkedIn Sosyal Simge
  • Facebook Social Icon
  • Twitter Social Icon

Bölükbaşı Pharmaceutical Industry Trade Limited Company ©  2021 All Rights Reserved.| Design : Bolukbasi

bottom of page